Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Raben David | Chief Medical Officer | 1 | $0 | $0 | 2026-10-01 |
| Borellini Flavia | Director | 1 | $0 | $0 | 2026-07-09 |
| Iannone Robert | Director | 1 | $0 | $0 | 2026-07-09 |
| Krognes Steve E. | Director | 3 | $0 | $0 | 2026-06-11 |
| Cline Darren S | Director | 5 | $0 | $0 | 2026-06-11 |
| Curnutte John T | Director | 6 | $0 | $0 | 2026-06-11 |
| MCCOURT Thomas A | Director | 5 | $0 | $0 | 2026-06-11 |
| Huh Hoyoung | Director | 8 | $0 | $0 | 2026-06-11 |
| CROWELL GAYLE A | Director | 6 | $0 | $0 | 2026-06-11 |
| Kuo Minnie | Chief Operating Officer | 8 | $0 | $8.9K | 2026-04-17 |
| Cheung Lily | Chief Human Resource Officer | 14 | $0 | $51.5K | 2026-04-17 |
| Cummings Keith Lamont | Chief Financial Officer | 67 | $0 | $2.97M | 2026-04-17 |
| Coulie Bernard | President and CEO | 123 | $0 | $13.58M | 2026-04-17 |
| Knobil Katharine | Director | 4 | $0 | $0 | 2025-06-05 |
| Bruhn Suzanne Louise | Director | 5 | $0 | $0 | 2025-06-05 |
| PYOTT DAVID E I | Director | 7 | $0 | $0 | 2025-06-05 |
| Ouimette Mike | General Counsel & Corp. Sec'y | 29 | $0 | $1.79M | 2025-01-23 |
| Hull Hans | Chief Business Officer | 35 | $0 | $1.89M | 2025-01-23 |
| Lefebvre Eric | Chief Medical Officer | 28 | $0 | $5.13M | 2025-01-23 |
| Shah Smital | Director | 4 | $0 | $0 | 2024-06-13 |
| Third Rock Ventures III, L.P. | 10% Owner | 2 | $0 | $0 | 2022-11-29 |
| Exter Neil | Director | 5 | $0 | $0 | 2022-06-16 |
| HOMCY CHARLES J | Director | 1 | $0 | $0 | 2021-06-29 |
| Howes Barbara | Chief Human Resource Officer | 5 | $0 | $0 | 2021-01-23 |
| TRV GP IV, LLC | 10% Owner | 4 | $0 | $0 | 2020-06-05 |
| Green Jeremy | 10% Owner | 2 | $0 | $0 | 2020-06-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Raben David | Chief Medical Officer | A Award deriv | 2026-10-01 | 2026-10-02 | 575,000 | — | $0 | 575,000 | SEC↗ |
| Borellini Flavia | Director | A Award deriv | 2026-07-09 | 2026-07-13 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Iannone Robert | Director | A Award deriv | 2026-07-09 | 2026-07-13 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Cline Darren S | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Huh Hoyoung | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Curnutte John T | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Krognes Steve E. | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| MCCOURT Thomas A | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CROWELL GAYLE A | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 51,750 | — | $0 | 0 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 51,750 | — | $0 | 51,750 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 123,000 | — | $0 | 0 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 123,000 | — | $0 | 123,000 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 52,000 | — | $0 | 0 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Coulie Bernard | President and CEO | D To issuer deriv | 2026-04-17 | 2026-04-17 | 146,841 | — | $0 | 0 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2026-04-17 | 2026-04-17 | 146,841 | — | $0 | 146,841 | SEC↗ |
| Coulie Bernard | President and CEO | D To issuer deriv | 2026-04-17 | 2026-04-17 | 327,262 | — | $0 | 0 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2026-04-17 | 2026-04-17 | 327,262 | — | $0 | 327,262 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2026-04-17 | 2026-04-17 | 325,000 | — | $0 | 325,000 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2026-04-17 | 2026-04-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Coulie Bernard | President and CEO | D To issuer deriv | 2026-04-17 | 2026-04-17 | 440,000 | — | $0 | 0 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2026-04-17 | 2026-04-17 | 440,000 | — | $0 | 440,000 | SEC↗ |
| Coulie Bernard | President and CEO | D To issuer deriv | 2026-04-17 | 2026-04-17 | 206,300 | — | $0 | 0 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2026-04-17 | 2026-04-17 | 206,300 | — | $0 | 206,300 | SEC↗ |
| Coulie Bernard | President and CEO | D To issuer deriv | 2026-04-17 | 2026-04-17 | 256,300 | — | $0 | 0 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2026-04-17 | 2026-04-17 | 256,300 | — | $0 | 256,300 | SEC↗ |
| Coulie Bernard | President and CEO | D To issuer deriv | 2026-04-17 | 2026-04-17 | 325,000 | — | $0 | 0 | SEC↗ |
| Coulie Bernard | President and CEO | D To issuer deriv | 2026-04-17 | 2026-04-17 | 250,000 | — | $0 | 0 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 18,198 | — | $0 | 18,198 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 74,250 | — | $0 | 0 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 76,200 | — | $0 | 0 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 18,198 | — | $0 | 0 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 76,047 | — | $0 | 76,047 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 76,047 | — | $0 | 0 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 74,250 | — | $0 | 74,250 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 76,200 | — | $0 | 76,200 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 110,500 | — | $0 | 0 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 110,500 | — | $0 | 110,500 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 113,300 | — | $0 | 0 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 113,300 | — | $0 | 113,300 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 124,000 | — | $0 | 0 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 124,000 | — | $0 | 124,000 | SEC↗ |
| Kuo Minnie | Chief Operating Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Kuo Minnie | Chief Operating Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 150,000 | — | $0 | 0 | SEC↗ |
| Kuo Minnie | Chief Operating Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Kuo Minnie | Chief Operating Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 55,200 | — | $0 | 0 | SEC↗ |
| Kuo Minnie | Chief Operating Officer | A Award deriv | 2026-04-17 | 2026-04-17 | 55,200 | — | $0 | 55,200 | SEC↗ |
| Kuo Minnie | Chief Operating Officer | D To issuer deriv | 2026-04-17 | 2026-04-17 | 40,000 | — | $0 | 0 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2026-01-22 | 2026-01-26 | 1,230,000 | — | $0 | 1,230,000 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | A Award deriv | 2026-01-22 | 2026-01-26 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Kuo Minnie | Chief Operating Officer | A Award deriv | 2026-01-22 | 2026-01-26 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2026-01-22 | 2026-01-26 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Kuo Minnie | Chief Operating Officer | S Sale | 2026-01-20 | 2026-01-22 | 6,917 | $1.28 | $8.9K | 37,806 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2026-01-20 | 2026-01-22 | 89,375 | $1.28 | $114.4K | 505,601 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | S Sale | 2026-01-20 | 2026-01-22 | 7,534 | $1.28 | $9.6K | 44,847 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | S Sale | 2026-01-20 | 2026-01-22 | 24,002 | $1.28 | $30.7K | 297,214 | SEC↗ |
| CROWELL GAYLE A | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Huh Hoyoung | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PYOTT DAVID E I | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Cline Darren S | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Krognes Steve E. | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Curnutte John T | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MCCOURT Thomas A | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Bruhn Suzanne Louise | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2025-01-23 | 2025-01-27 | 325,000 | — | $0 | 325,000 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2025-01-23 | 2025-01-27 | 113,300 | — | $0 | 113,300 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award deriv | 2025-01-23 | 2025-01-27 | 91,300 | — | $0 | 91,300 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award deriv | 2025-01-23 | 2025-01-27 | 80,300 | — | $0 | 80,300 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award deriv | 2025-01-23 | 2025-01-27 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | A Award deriv | 2025-01-23 | 2025-01-27 | 51,750 | — | $0 | 51,750 | SEC↗ |
| Coulie Bernard | President and CEO | A Award | 2025-01-23 | 2025-01-27 | 162,500 | — | $0 | 593,017 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award | 2025-01-23 | 2025-01-27 | 56,650 | — | $0 | 319,258 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award | 2025-01-23 | 2025-01-27 | 45,650 | — | $0 | 240,224 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award | 2025-01-23 | 2025-01-27 | 40,150 | — | $0 | 251,708 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award | 2025-01-23 | 2025-01-27 | 35,000 | — | $0 | 105,544 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | A Award | 2025-01-23 | 2025-01-27 | 25,875 | — | $0 | 50,425 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2025-01-22 | 2025-01-22 | 10,230 | $10.99 | $112.4K | 70,544 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2025-01-17 | 2025-01-22 | 13,270 | $11.20 | $148.6K | 80,774 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | S Sale | 2025-01-17 | 2025-01-22 | 3,740 | $11.20 | $41.9K | 24,550 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2025-01-17 | 2025-01-22 | 18,478 | $11.20 | $207.0K | 194,574 | SEC↗ |
| Hull Hans | Chief Business Officer | S Sale | 2025-01-17 | 2025-01-22 | 15,936 | $11.20 | $178.5K | 211,558 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | S Sale | 2025-01-17 | 2025-01-22 | 20,148 | $11.20 | $225.7K | 262,608 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2025-01-17 | 2025-01-22 | 52,419 | $11.20 | $587.1K | 430,517 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2024-07-10 | 2024-07-12 | 7,656 | $11.56 | $88.5K | 94,044 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2024-07-10 | 2024-07-12 | 38,710 | $11.56 | $447.5K | 482,936 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | S Sale | 2024-07-10 | 2024-07-12 | 10,911 | $11.56 | $126.1K | 282,115 | SEC↗ |
| Hull Hans | Chief Business Officer | S Sale | 2024-07-10 | 2024-07-12 | 9,900 | $11.56 | $114.4K | 227,494 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2024-07-10 | 2024-07-12 | 12,319 | $11.56 | $142.4K | 213,052 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award | 2024-07-09 | 2024-07-11 | 14,954 | — | $0 | 101,700 | SEC↗ |
| Coulie Bernard | President and CEO | A Award | 2024-07-09 | 2024-07-11 | 75,625 | — | $0 | 521,646 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award | 2024-07-09 | 2024-07-11 | 21,313 | — | $0 | 293,026 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award | 2024-07-09 | 2024-07-11 | 19,337 | — | $0 | 237,394 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award | 2024-07-09 | 2024-07-11 | 24,063 | — | $0 | 225,371 | SEC↗ |
| Krognes Steve E. | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 53,528 | — | $0 | 53,528 | SEC↗ |
| Curnutte John T | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| Bruhn Suzanne Louise | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| CROWELL GAYLE A | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| Cline Darren S | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| Shah Smital | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| PYOTT DAVID E I | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| Huh Hoyoung | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| MCCOURT Thomas A | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise deriv | 2024-05-02 | 2024-05-06 | 21,000 | — | $0 | 76,047 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise | 2024-05-02 | 2024-05-06 | 21,000 | $2.08 | $43.7K | 271,713 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2024-01-23 | 2024-01-24 | 256,300 | — | $0 | 256,300 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | A Award deriv | 2024-01-23 | 2024-01-24 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2024-01-23 | 2024-01-24 | 110,500 | — | $0 | 110,500 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award deriv | 2024-01-23 | 2024-01-24 | 63,000 | — | $0 | 63,000 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award deriv | 2024-01-23 | 2024-01-24 | 63,000 | — | $0 | 63,000 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award deriv | 2024-01-23 | 2024-01-24 | 85,800 | — | $0 | 85,800 | SEC↗ |
| Coulie Bernard | President and CEO | A Award | 2024-01-23 | 2024-01-24 | 128,150 | — | $0 | 444,532 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | A Award | 2024-01-23 | 2024-01-24 | 26,000 | — | $0 | 26,795 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award | 2024-01-23 | 2024-01-24 | 55,250 | — | $0 | 249,855 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award | 2024-01-23 | 2024-01-24 | 31,500 | — | $0 | 86,746 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award | 2024-01-23 | 2024-01-24 | 31,500 | — | $0 | 216,569 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award | 2024-01-23 | 2024-01-24 | 42,900 | — | $0 | 199,820 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2024-01-17 | 2024-01-19 | 5,197 | $17.23 | $89.5K | 55,246 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2024-01-17 | 2024-01-19 | 10,295 | $17.23 | $177.4K | 156,920 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2024-01-17 | 2024-01-19 | 25,721 | $17.23 | $443.2K | 316,382 | SEC↗ |
| Hull Hans | Chief Business Officer | S Sale | 2024-01-17 | 2024-01-19 | 9,786 | $17.23 | $168.6K | 185,069 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | S Sale | 2024-01-17 | 2024-01-19 | 9,781 | $17.23 | $168.5K | 194,605 | SEC↗ |
| Hull Hans | Chief Business Officer | M Exercise deriv | 2023-08-04 | 2023-08-07 | 8,791 | — | $0 | 31,367 | SEC↗ |
| Hull Hans | Chief Business Officer | M Exercise | 2023-08-04 | 2023-08-07 | 8,791 | $2.08 | $18.3K | 214,905 | SEC↗ |
| Hull Hans | Chief Business Officer | S Sale | 2023-08-04 | 2023-08-07 | 20,050 | $20.01 | $401.2K | 194,855 | SEC↗ |
| Hull Hans | Chief Business Officer | M Exercise deriv | 2023-08-03 | 2023-08-07 | 1,800 | — | $0 | 40,158 | SEC↗ |
| Hull Hans | Chief Business Officer | S Sale | 2023-08-03 | 2023-08-07 | 1,800 | $20.00 | $36.0K | 206,114 | SEC↗ |
| Hull Hans | Chief Business Officer | S Sale | 2023-08-03 | 2023-08-07 | 13,069 | $20.00 | $261.4K | 206,114 | SEC↗ |
| Hull Hans | Chief Business Officer | M Exercise | 2023-08-03 | 2023-08-07 | 1,800 | $2.08 | $3.7K | 207,914 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2023-07-20 | 2023-07-21 | 4,755 | $17.55 | $83.5K | 60,443 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-07-17 | 2023-07-19 | 70,150 | $18.01 | $1.26M | 342,103 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | S Sale | 2023-07-17 | 2023-07-19 | 19,771 | $18.01 | $356.1K | 203,999 | SEC↗ |
| Hull Hans | Chief Business Officer | S Sale | 2023-07-17 | 2023-07-19 | 17,937 | $18.01 | $323.0K | 219,183 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2023-07-17 | 2023-07-19 | 22,321 | $18.01 | $402.0K | 167,215 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2023-07-17 | 2023-07-19 | 12,778 | $18.01 | $230.1K | 65,198 | SEC↗ |
| Coulie Bernard | President and CEO | A Award | 2023-07-14 | 2023-07-18 | 137,500 | — | $0 | 412,253 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award | 2023-07-14 | 2023-07-18 | 38,750 | — | $0 | 223,770 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award | 2023-07-14 | 2023-07-18 | 35,156 | — | $0 | 237,120 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award | 2023-07-14 | 2023-07-18 | 43,750 | — | $0 | 189,536 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award | 2023-07-14 | 2023-07-18 | 27,187 | — | $0 | 77,976 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise deriv | 2023-06-13 | 2023-06-14 | 30,750 | — | $0 | 97,047 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise | 2023-06-13 | 2023-06-14 | 30,750 | $2.08 | $64.0K | 185,020 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise deriv | 2023-06-09 | 2023-06-12 | 5,800 | — | $0 | 127,797 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise | 2023-06-09 | 2023-06-12 | 5,800 | $2.08 | $12.1K | 154,270 | SEC↗ |
| Bruhn Suzanne Louise | Director | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Cline Darren S | Director | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CROWELL GAYLE A | Director | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Curnutte John T | Director | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Huh Hoyoung | Director | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| MCCOURT Thomas A | Director | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PYOTT DAVID E I | Director | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Shah Smital | Director | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2023-04-03 | 2023-04-03 | 200 | $27.46 | $5.5K | 50,789 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2023-04-03 | 2023-04-03 | 2,677 | $26.74 | $71.6K | 50,989 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-03-30 | 2023-04-03 | 35,339 | $26.52 | $937.2K | 274,753 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | S Sale | 2023-03-30 | 2023-04-03 | 9,960 | $26.52 | $264.1K | 148,470 | SEC↗ |
| Hull Hans | Chief Business Officer | S Sale | 2023-03-30 | 2023-04-03 | 9,036 | $26.52 | $239.6K | 201,964 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2023-03-30 | 2023-04-03 | 11,245 | $26.52 | $298.2K | 145,786 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2023-03-30 | 2023-04-03 | 4,874 | $26.52 | $129.3K | 53,666 | SEC↗ |
| Coulie Bernard | President and CEO | A Award | 2023-03-29 | 2023-03-31 | 68,749 | — | $0 | 310,092 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award | 2023-03-29 | 2023-03-31 | 19,375 | — | $0 | 158,430 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award | 2023-03-29 | 2023-03-31 | 17,578 | — | $0 | 211,000 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award | 2023-03-29 | 2023-03-31 | 21,874 | — | $0 | 157,031 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award | 2023-03-29 | 2023-03-31 | 13,593 | — | $0 | 58,540 | SEC↗ |
| Cline Darren S | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MCCOURT Thomas A | Director | A Award deriv | 2023-03-06 | 2023-03-08 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-02-03 | 2023-02-06 | 15,000 | — | $0 | 327,262 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-02-03 | 2023-02-06 | 9,738 | $33.36 | $324.9K | 245,374 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-02-03 | 2023-02-06 | 15,000 | $6.22 | $93.3K | 255,112 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-02-03 | 2023-02-06 | 5,262 | $34.08 | $179.3K | 240,112 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-02-02 | 2023-02-06 | 15,000 | — | $0 | 342,262 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-02-02 | 2023-02-06 | 15,000 | $6.22 | $93.3K | 255,112 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-02-02 | 2023-02-06 | 13,395 | $34.13 | $457.2K | 241,717 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-02-02 | 2023-02-06 | 1,605 | $34.96 | $56.1K | 240,112 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-02-01 | 2023-02-01 | 15,000 | — | $0 | 357,262 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-02-01 | 2023-02-01 | 105 | $35.55 | $3.7K | 240,112 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-02-01 | 2023-02-01 | 5,440 | $34.78 | $189.2K | 240,217 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-02-01 | 2023-02-01 | 9,455 | $34.15 | $322.9K | 245,657 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-02-01 | 2023-02-01 | 15,000 | $6.22 | $93.3K | 255,112 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-31 | 2023-02-01 | 10,539 | — | $0 | 146,841 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-31 | 2023-02-01 | 4,461 | — | $0 | 372,262 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-31 | 2023-02-01 | 4,461 | $6.22 | $27.7K | 255,112 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-31 | 2023-02-01 | 15,000 | $34.92 | $523.8K | 240,112 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-31 | 2023-02-01 | 10,539 | $2.08 | $21.9K | 250,651 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-30 | 2023-02-01 | 15,000 | — | $0 | 157,380 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-30 | 2023-02-01 | 15,000 | $2.08 | $31.2K | 255,112 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-30 | 2023-02-01 | 11,395 | $33.98 | $387.2K | 243,717 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-30 | 2023-02-01 | 3,605 | $34.66 | $124.9K | 240,112 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-27 | 2023-01-27 | 9,779 | $35.09 | $343.1K | 409,538 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-27 | 2023-01-27 | 221 | $36.64 | $8.1K | 409,317 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-27 | 2023-01-27 | 6,302 | $36.06 | $227.3K | 240,112 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-27 | 2023-01-27 | 8,698 | $35.42 | $308.1K | 246,414 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-27 | 2023-01-27 | 15,000 | $2.08 | $31.2K | 255,112 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-26 | 2023-01-27 | 15,000 | — | $0 | 187,380 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-26 | 2023-01-27 | 15,000 | — | $0 | 172,380 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-26 | 2023-01-27 | 15,000 | $35.10 | $526.5K | 419,317 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-26 | 2023-01-27 | 15,000 | $2.08 | $31.2K | 255,112 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-26 | 2023-01-27 | 15,000 | $35.29 | $529.4K | 240,112 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-25 | 2023-01-25 | 15,000 | — | $0 | 202,380 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2023-01-25 | 2023-01-27 | 206,300 | — | $0 | 206,300 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award deriv | 2023-01-25 | 2023-01-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award deriv | 2023-01-25 | 2023-01-27 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award deriv | 2023-01-25 | 2023-01-27 | 76,200 | — | $0 | 76,200 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2023-01-25 | 2023-01-27 | 76,200 | — | $0 | 76,200 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-25 | 2023-01-25 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-25 | 2023-01-25 | 1,696 | $33.29 | $56.5K | 93,812 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-25 | 2023-01-25 | 13,304 | $32.40 | $431.0K | 95,508 | SEC↗ |
| Coulie Bernard | President and CEO | A Award | 2023-01-25 | 2023-01-27 | 146,300 | — | $0 | 240,112 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award | 2023-01-25 | 2023-01-27 | 57,000 | — | $0 | 133,926 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award | 2023-01-25 | 2023-01-27 | 39,000 | — | $0 | 44,947 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award | 2023-01-25 | 2023-01-27 | 54,000 | — | $0 | 192,191 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award | 2023-01-25 | 2023-01-27 | 54,000 | — | $0 | 138,424 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-24 | 2023-01-25 | 15,000 | — | $0 | 217,380 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-24 | 2023-01-25 | 15,000 | $30.89 | $463.4K | 93,812 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-24 | 2023-01-25 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise deriv | 2023-01-23 | 2023-01-25 | 17,500 | — | $0 | 18,198 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise deriv | 2023-01-23 | 2023-01-25 | 12,500 | — | $0 | 133,597 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | M Exercise deriv | 2023-01-23 | 2023-01-25 | 10,000 | — | $0 | 98,240 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | M Exercise deriv | 2023-01-23 | 2023-01-25 | 10,000 | — | $0 | 77,000 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-23 | 2023-01-25 | 15,000 | — | $0 | 232,380 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | S Sale | 2023-01-23 | 2023-01-25 | 30,000 | $35.00 | $1.05M | 84,424 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise | 2023-01-23 | 2023-01-25 | 12,500 | $2.08 | $26.0K | 96,924 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise | 2023-01-23 | 2023-01-25 | 17,500 | $6.22 | $108.8K | 114,424 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2023-01-23 | 2023-01-25 | 67,500 | $34.48 | $2.33M | 76,926 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2023-01-23 | 2023-01-25 | 20,000 | $34.19 | $683.8K | 5,947 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | M Exercise | 2023-01-23 | 2023-01-25 | 10,000 | $24.32 | $243.2K | 25,947 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | M Exercise | 2023-01-23 | 2023-01-25 | 10,000 | $11.86 | $118.6K | 15,947 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-23 | 2023-01-25 | 10,150 | $33.71 | $342.2K | 98,662 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-23 | 2023-01-25 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-23 | 2023-01-25 | 4,850 | $34.93 | $169.4K | 93,812 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-23 | 2023-01-25 | 15,000 | $35.00 | $525.0K | 434,317 | SEC↗ |
| Cheung Lily | Chief Human Resource Officer | A Award deriv | 2023-01-19 | 2023-01-23 | 123,000 | — | $0 | 123,000 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-09 | 2023-01-09 | 5,000 | — | $0 | 247,380 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-09 | 2023-01-09 | 5,000 | $19.17 | $95.9K | 93,812 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-09 | 2023-01-09 | 5,000 | $2.08 | $10.4K | 98,812 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-06 | 2023-01-09 | 15,000 | — | $0 | 252,380 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-06 | 2023-01-09 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-06 | 2023-01-09 | 15,000 | $19.04 | $285.6K | 93,812 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-04 | 2023-01-05 | 15,000 | — | $0 | 267,380 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-04 | 2023-01-05 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-04 | 2023-01-05 | 15,000 | $19.06 | $285.9K | 93,812 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2023-01-03 | 2023-01-05 | 15,000 | — | $0 | 282,380 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2023-01-03 | 2023-01-05 | 15,000 | $19.33 | $289.9K | 93,812 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2023-01-03 | 2023-01-05 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise deriv | 2022-12-22 | 2022-12-27 | 4,000 | — | $0 | 146,097 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2022-12-22 | 2022-12-23 | 2,928 | $19.38 | $56.7K | 5,947 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise | 2022-12-22 | 2022-12-27 | 4,000 | $2.08 | $8.3K | 84,424 | SEC↗ |
| Hull Hans | Chief Business Officer | S Sale | 2022-12-20 | 2022-12-21 | 8,748 | $19.10 | $167.1K | 138,191 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | S Sale | 2022-12-20 | 2022-12-21 | 4,719 | $19.10 | $90.1K | 8,875 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2022-12-20 | 2022-12-21 | 10,887 | $19.10 | $207.9K | 144,426 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2022-12-20 | 2022-12-21 | 34,212 | $19.10 | $653.4K | 93,812 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | S Sale | 2022-12-20 | 2022-12-21 | 9,643 | $19.10 | $184.2K | 80,424 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award | 2022-12-19 | 2022-12-21 | 17,578 | — | $0 | 146,939 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award | 2022-12-19 | 2022-12-21 | 13,594 | — | $0 | 13,594 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award | 2022-12-19 | 2022-12-21 | 21,876 | — | $0 | 155,313 | SEC↗ |
| Coulie Bernard | President and CEO | A Award | 2022-12-19 | 2022-12-21 | 68,751 | — | $0 | 128,024 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award | 2022-12-19 | 2022-12-21 | 19,375 | — | $0 | 90,067 | SEC↗ |
| Third Rock Ventures III, L.P. | 10% Owner | J Other | 2022-11-29 | 2022-12-01 | 2,000,000 | — | $0 | 1,839,160 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2022-10-25 | 2022-10-27 | 5,000 | $25.05 | $125.3K | 133,437 | SEC↗ |
| Third Rock Ventures III, L.P. | 10% Owner | J Other | 2022-09-20 | 2022-09-22 | 2,000,000 | — | $0 | 3,839,160 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2022-09-14 | 2022-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2022-09-12 | 2022-09-14 | 12,502 | — | $0 | 297,380 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2022-09-12 | 2022-09-14 | 12,502 | $2.08 | $26.0K | 71,775 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2022-09-12 | 2022-09-14 | 12,502 | $22.54 | $281.8K | 59,273 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2022-07-12 | 2022-07-13 | 12,498 | — | $0 | 309,882 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2022-07-12 | 2022-07-13 | 12,498 | $2.08 | $26.0K | 71,771 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2022-07-12 | 2022-07-13 | 12,498 | $22.50 | $281.2K | 59,273 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise deriv | 2022-07-11 | 2022-07-13 | 15,000 | — | $0 | 322,380 | SEC↗ |
| Coulie Bernard | President and CEO | S Sale | 2022-07-11 | 2022-07-13 | 15,000 | $22.50 | $337.5K | 59,273 | SEC↗ |
| Coulie Bernard | President and CEO | M Exercise | 2022-07-11 | 2022-07-13 | 15,000 | $2.08 | $31.2K | 74,273 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2022-07-11 | 2022-07-13 | 3,000 | $20.00 | $60.0K | 138,436 | SEC↗ |
| Shah Smital | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Bruhn Suzanne Louise | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CROWELL GAYLE A | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Curnutte John T | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Exter Neil | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Huh Hoyoung | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PYOTT DAVID E I | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Coulie Bernard | President and CEO | A Award deriv | 2022-01-26 | 2022-02-02 | 440,000 | — | $0 | 440,000 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | A Award deriv | 2022-01-26 | 2022-02-02 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Hull Hans | Chief Business Officer | A Award deriv | 2022-01-26 | 2022-02-02 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | A Award deriv | 2022-01-26 | 2022-02-02 | 124,000 | — | $0 | 124,000 | SEC↗ |
| Ouimette Mike | General Counsel & Corp. Sec' | A Award deriv | 2022-01-26 | 2022-02-02 | 87,000 | — | $0 | 87,000 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise deriv | 2021-09-03 | 2021-09-03 | 20,000 | — | $0 | 150,097 | SEC↗ |
| Cummings Keith Lamont | Chief Financial Officer | M Exercise | 2021-09-03 | 2021-09-03 | 20,000 | $2.08 | $41.6K | 67,621 | SEC↗ |
| PYOTT DAVID E I | Director | A Award deriv | 2021-06-29 | 2021-07-01 | 13,286 | — | $0 | 13,286 | SEC↗ |
| Bruhn Suzanne Louise | Director | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| CROWELL GAYLE A | Director | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| Curnutte John T | Director | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| Exter Neil | Director | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| HOMCY CHARLES J | Director | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| Huh Hoyoung | Director | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| PYOTT DAVID E I | Director | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| Shah Smital | Director | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2021-06-18 | 2021-06-22 | 3,728 | $29.43 | $109.7K | 137,102 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2021-06-18 | 2021-06-22 | 22 | $30.23 | $665 | 137,080 | SEC↗ |
| Lefebvre Eric | Chief Medical Officer | S Sale | 2021-06-18 | 2021-06-22 | 8,750 | $28.62 | $250.4K | 140,830 | SEC↗ |